Sign inGet started

KLRS

Kalaris Therapeutics, Inc.CIK 1754068 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17

AI insights for KLRS PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for KLRS
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Vandekop Amy O'LearyVP, Corporate Controller2$0$02026-08-27
KEATING LAURIEDirector2$0$02026-08-01
Bayko Liisa AnnChief Financial Officer1$0$02026-07-20
Ferrara NapoleoneDirector3$0$02026-06-03
Dybbs MichaelDirector2$0$02026-06-03
Jovan-Embiricos MoranaDirector2$0$02026-06-03
Hallal DavidDirector2$0$02026-06-03
ADAMIS ANTHONY PDirector4$0$02026-06-03
AKKARAJU SRINIVASDirector, 10% Owner4$0$02026-06-03
PATTERSON LEONE DDirector2$0$02026-06-03
Samsara BioCapital, L.P.10% Owner4$1.18M$02026-05-20
Hagen Brett RChief Accounting Officer4$0$21.0K2026-03-20
Gall MatthewChief Financial Officer2$0$02026-03-19
Oxtoby AndrewSee Remarks3$0$02026-03-19
Feinsod MatthewChief Medical Officer5$0$02026-03-19
Samsara Opportunity Fund, L.P.10% Owner1$5.00M$02025-12-18
PATEL SAMIR CHANDRAKANTDirector4$0$02025-04-10

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Vandekop Amy O'LearyVP, Corporate Controller A Award deriv2026-08-272026-08-2810,000— $010,000SEC↗
Vandekop Amy O'LearyVP, Corporate Controller A Award deriv2026-08-272026-08-2810,000— $010,000SEC↗
KEATING LAURIEDirector A Award deriv2026-08-012026-08-0318,000— $018,000SEC↗
KEATING LAURIEDirector A Award deriv2026-08-012026-08-0318,000— $018,000SEC↗
Bayko Liisa AnnChief Financial Officer A Award deriv2026-07-202026-07-20220,000— $0220,000SEC↗
PATTERSON LEONE DDirector A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
ADAMIS ANTHONY PDirector A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
Dybbs MichaelDirector A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
AKKARAJU SRINIVASDirector A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
Hallal DavidDirector A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
Ferrara NapoleoneDirector A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
Jovan-Embiricos MoranaDirector A Award deriv2026-06-032026-06-049,000— $09,000SEC↗
Samsara BioCapital, L.P.10% Owner J Other2026-05-202026-05-2214,937— $014,937SEC↗
Samsara BioCapital, L.P.10% Owner P Buy2026-05-202026-05-22244,300$4.83 $1.18M2,224,147SEC↗
Samsara BioCapital, L.P.10% Owner J Other2026-05-202026-05-2266,906— $010,657,028SEC↗
Samsara BioCapital, L.P.10% Owner J Other2026-05-202026-05-224,471— $019,408SEC↗
Hagen Brett RChief Accounting Officer S Sale2026-03-202026-03-231,915$6.72 $12.9K0SEC↗
Feinsod MatthewChief Medical Officer A Award deriv2026-03-192026-03-20135,000— $0135,000SEC↗
Gall MatthewChief Financial Officer A Award deriv2026-03-192026-03-2095,000— $095,000SEC↗
Oxtoby AndrewSee Remarks A Award deriv2026-03-192026-03-20222,000— $0222,000SEC↗
Hagen Brett RChief Accounting Officer A Award deriv2026-03-192026-03-2360,800— $060,800SEC↗
AKKARAJU SRINIVASDirector, 10% Owner A Award2025-12-222025-12-221,500,000$10.00 $15.00M1,500,000SEC↗
Samsara Opportunity Fund, L.P.10% Owner P Buy2025-12-182026-02-17479,847$10.42 $5.00M1,979,847SEC↗
Gall MatthewChief Financial Officer A Award deriv2025-11-032025-11-03235,000— $0235,000SEC↗
Hallal DavidDirector A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
PATTERSON LEONE DDirector A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
Feinsod MatthewChief Medical Officer A Award deriv2025-04-102025-04-11101,000— $0101,000SEC↗
Feinsod MatthewChief Medical Officer A Award deriv2025-04-102025-04-1170,551— $070,551SEC↗
ADAMIS ANTHONY PDirector A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
Oxtoby AndrewSee Remarks A Award deriv2025-04-102025-04-11287,000— $0287,000SEC↗
Dybbs MichaelDirector A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
Ferrara NapoleoneDirector A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
PATEL SAMIR CHANDRAKANTDirector A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
Jovan-Embiricos MoranaDirector A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
AKKARAJU SRINIVASDirector, 10% Owner A Award deriv2025-04-102025-04-1118,000— $018,000SEC↗
Hagen Brett RChief Accounting Officer A Award deriv2025-04-102025-04-1150,262— $050,262SEC↗
Hagen Brett RChief Accounting Officer S Sale2025-03-262025-03-27907$8.97 $8.1K1,925SEC↗
ADAMIS ANTHONY PDirector A Award deriv2025-03-182025-03-1819,484— $019,484SEC↗
ADAMIS ANTHONY PDirector A Award deriv2025-03-182025-03-1812,989— $012,989SEC↗
Oxtoby AndrewSee Remarks A Award deriv2025-03-182025-03-18476,611— $0476,611SEC↗
Feinsod MatthewChief Medical Officer A Award deriv2025-03-182025-03-1828,224— $028,224SEC↗
PATEL SAMIR CHANDRAKANTDirector A Award deriv2025-03-182025-03-18105,913— $0105,913SEC↗
AKKARAJU SRINIVASDirector, 10% Owner A Award2025-03-182025-03-1811,444,503— $011,444,503SEC↗
Feinsod MatthewChief Medical Officer A Award2025-03-182025-03-184,030— $04,030SEC↗
PATEL SAMIR CHANDRAKANTDirector A Award2025-03-182025-03-18252,000— $0252,000SEC↗
PATEL SAMIR CHANDRAKANTDirector A Award2025-03-182025-03-18100,800— $0100,800SEC↗
Ferrara NapoleoneDirector A Award2025-03-182025-03-18504,000— $0504,000SEC↗